Advisory Board

 

Uwe Gudat

Uwe Gudat 
Head of Safety, Biosimilars 
Merck

Alain Beck

Alain Beck 
Senior Director Analytical Chemistry, CIPF and Associate Editor 
mAbs 

Paul Chrisp

Paul Chrisp 
Programme Director, Medicines and Prescribing Center 
NICE

Gianluca Trifirò

Gianluca Trifirò 
Assistant Professor of Pharmacology 
Erasmus Medical Center

 Cecil Nick

Cecil Nick
Vice President, Biotechnology
PAREXEL

Steinar Madsen

Steinar Madsen
Medical Director, Department of Drug Information
Norwegian Medicines Agency

Ingrid Schwarzenberger

Ingrid Schwarzenberger
Head Global Regulatory Affair
Sandoz Biopharmaceuticals

adam levysohn

Adam Levysohn
Head of Global Market Access Biogen Biosimilars Business Unit
Biogen

Jonathan Underhill, Associate Director for Medicines Evidence, NICE

Jonathan Underhill
Associate Director for Medicines Evidence
NICE

Jatinder Harchowal, Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit Pharmacy Dept, The Royal Marsden NHS Foundation Trust

Jatinder Harchowal
Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit Pharmacy Dept
The Royal Marsden NHS Foundation Trust

Philip Ball, Market Access Manager, NAPP Pharmaceuticals

Philip Ball Market Access Manager
NAPP Pharmaceuticals

 

JOIN THE ADVISORY BOARD

 

Co-located with 

Part of


World Biosimilar Congress 29-30 October, Basel, Switzerland

Part of the  Festival of Biologics

Sign Up for Event Updates